Stethophone

St. John's, Canada Founded: 2021 • Age: 5 yrs
Smartphone-based stethoscope for cardiac and pulmonary data is provided.
Annual revenue $2.5M Latest available
Total funding $16.2M 2 rounds
Employees 82 Tracked headcount
Investors 3 Known backers
Products - Services tracked
Competitors 9 Brand Intelligence

About Stethophone

Stethophone is a company based in St. John's (Canada) founded in 2021 by Nadia Ivanova and Yaroslav Shpak. Stethophone has raised $16.25 million across 2 funding rounds from investors including Killick Capital, Klister Credit and Pelorus Venture Capital. The company has 82 employees as of March 28, 2024. Stethophone operates in a competitive market with competitors including eKuore, HD Medical Group, AiSteth, AMI Corporation and Laennec AI, among others.

  • Headquarter St. John's, Canada
  • Employees 82 as on 28 Mar, 2024
  • Founders Nadia Ivanova, Yaroslav Shpak
  • Sectors
    Healthcare
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Jurisdiction Delhi, Delhi, India
Operational Areas
Healthcare → Health Technology & Digital Health
Key Metrics
  • Annual Revenue
    $2.54 M (USD)
    83.4
    as on Mar 31, 2023
  • Net Profit
    $264.56 K (USD)
    200.9
    as on Mar 31, 2023
  • EBITDA
    $524.72 K (USD)
    289.19
    as on Mar 31, 2023
  • Total Equity Funding
    $16.25 M (USD)

    in 2 rounds

  • Latest Funding Round
    $13 M (USD), Seed

    Sep 20, 2024

  • Investors
  • Employee Count
    82

    as on Mar 28, 2024

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of Stethophone

Stethophone has successfully raised a total of $16.25M across 2 strategic funding rounds. The most recent funding activity was a Seed round of $13 million completed in September 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 2
  • Last Round Seed — $13.0M
  • First Round

    (16 Sep 2021)

  • Investors Count 3
Date Amount Transaction Name Valuation Lead Investors Investors
Sep, 2024 Amount Seed - Stethophone Valuation Killick Capital , Klister Credit
Sep, 2021 Amount Seed - Stethophone Valuation

investors

Investors in Stethophone

Stethophone has secured backing from 3 investors, including venture fund investors. Prominent investors backing the company include Killick Capital, Klister Credit and Pelorus Venture Capital.

All
Venture Fund
Investor Description Founded Year Domain Location
Killick Capital is engaged in private equity investments in Canada.
Founded Year Domain Location
Family office backed private equity investment firm based out of Canada
Founded Year Domain Location
A venture capital fund focused on pre-seed investments in Newfoundland and Labrador.
Founded Year Domain Location

Investments & Acquisitions by Stethophone

Investments

Financial Statements - Stethophone

Stethophone Comparisons

+
Add Comparison
Available on Premium

Competitors of Stethophone

Stethophone operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as eKuore, HD Medical Group, AiSteth, AMI Corporation and Laennec AI, among others.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Wireless electronic stethoscopes are developed for cardiac anomaly detection.
domain founded_year HQ Location
Developer of stethoscopes with integrated phonocardiogram visual display
domain founded_year HQ Location
A smart stethoscope for cardiac screening is developed.
domain founded_year HQ Location
Stethoscopes for heart disease diagnosis are provided by AMI Corporation.
domain founded_year HQ Location
AI-powered digital stethoscope and companion app for professionals

Frequently Asked Questions about Stethophone

Stethophone was founded in 2021.

Stethophone is headquartered in St. John's, Canada. It is registered at St. John's, Newfoundland And Labrador, Canada.

Mark Attila Opauszky is the current CEO of Stethophone.

Stethophone is a funded company, having raised a total of $16.25M across 2 funding rounds to date. The company's 1st funding round was a Seed of $3.25M, raised on Sep 16, 2021.

As of Mar 28, 2024, the latest employee count at Stethophone is 82.

Annual revenue of Stethophone is $2.54M as on Mar 31, 2023.

Stethophone was established in 2021 in St. Johns, Canada, within the health technology sector. A smartphone app named Stethophoney has been developed to enable collection of medical-grade cardiac and pulmonary data using only a smartphone. The tool is utilized by medical professionals for diagnostics and by individuals managing cardiac or pulmonary conditions. Operations focus on accessible remote monitoring solutions.

Stethophone's top competitors include AMI Corporation, eKuore and AiSteth.

Stethophone has 3 investors. Key investors include Killick Capital, Klister Credit, and Pelorus Venture Capital.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available